Showing results (381-390 of 396) with videos related to
Sort By:
Pageof 40
Cancer Discovery|August 26, 2022
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung TumorsJohn A Grout, Philemon Sirven, Andrew M Leader, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2021
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I StudyKeunchil Park, Eric B Haura, Natasha B Leighl, et al.Targeted Oncology|November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON StudyRachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology CommitteeSylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, et al.Ebiomedicine|October 26, 2019
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactionsNicolas Alcala, Lise Mangiante, Nolwenn Le-Stang, et al.Cancer Cell|February 14, 2018
The Integrated Genomic Landscape of Thymic Epithelial TumorsMilan Radovich, Curtis R Pickering, Ina Felau, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2019
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary ApproachAndrew G Nicholson, Jennifer L Sauter, Anna K Nowak, et al.The Lancet. Respiratory Medicine|August 14, 2018
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysisMichäel Duruisseaux, Anna Martínez-Cardús, Maria E Calleja-Cervantes, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 14, 2020
Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference CenterFrancoise Galateau Salle, Nolwenn Le Stang, Franck Tirode, et al.Lung Cancer (Amsterdam, Netherlands)|October 18, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer GroupMariana Brandão, Elena Prisciandaro, Eleni Xenophontos, et al.Pageof 40